{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:36:14Z","timestamp":1791657374297,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007911","name":"University of California, San Diego","doi-asserted-by":"publisher","award":["P30NS047101"],"award-info":[{"award-number":["P30NS047101"]}],"id":[{"id":"10.13039\/100007911","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jtha.2025.08.016","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T23:49:05Z","timestamp":1756856945000},"page":"88-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Defective lymphangiogenesis and iron removal after hemarthrosis in factor VIII-deficient mice are rectified with therapeutic factor VIII administration\u2014implications for joint health"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2756-4546","authenticated-orcid":false,"given":"Bilgimol","family":"Chumappumkal Joseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Andres","family":"De Pablo-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicca","family":"Falah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Lora Cacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"von Drygalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.08.016_bib1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/(SICI)1096-8652(199812)59:4<288::AID-AJH4>3.0.CO;2-I","article-title":"Occurrence of hemophilia in the United States. The Hemophilia Surveillance System Project Investigators","volume":"59","author":"Soucie","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2025.08.016_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/jcm6070063","article-title":"Pathophysiology of hemophilic arthropathy","volume":"6","author":"Melchiorre","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtha.2025.08.016_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.seminhematol.2015.10.005","article-title":"Advances and challenges in hemophilic arthropathy","volume":"53","author":"Wyseure","year":"2016","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtha.2025.08.016_bib4","doi-asserted-by":"crossref","first-page":"e730","DOI":"10.1111\/hae.14417","article-title":"Bleeding with iron deposition and vascular remodelling in subchondral cysts: A newly discovered feature unique to haemophilic arthropathy","volume":"27","author":"Zhou","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.08.016_bib5","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/ajh.24133","article-title":"Vascular remodeling underlies rebleeding in hemophilic arthropathy","volume":"90","author":"Bhat","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2025.08.016_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/jth.12101","article-title":"Nuclear factor (NF)-\u03baB and its associated pathways are major molecular regulators of blood-induced joint damage in a murine model of hemophilia","volume":"11","author":"Sen","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.016_bib7","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1055\/s-0038-1641755","article-title":"Vascular permeability and remodelling coincide with inflammatory and reparative processes after joint bleeding in factor VIII-deficient mice","volume":"118","author":"Cooke","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.016_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11420-011-9250-z","article-title":"Articular cartilage degradation in osteoarthritis","volume":"8","author":"Goldring","year":"2012","journal-title":"HSS J"},{"key":"10.1016\/j.jtha.2025.08.016_bib9","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/jclinpath-2015-202967","article-title":"The detrimental effects of iron on the joint: a comparison between haemochromatosis and haemophilia","volume":"68","author":"van Vulpen","year":"2015","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jtha.2025.08.016_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/hae.13802","article-title":"Advanced magnetic resonance imaging of cartilage components in haemophilic joints reveals that cartilage hemosiderin correlates with joint deterioration","volume":"25","author":"von Drygalski","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.08.016_bib11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.phrs.2016.11.032","article-title":"Pathophysiology of hemophilic arthropathy and potential targets for therapy","volume":"115","author":"Pulles","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jtha.2025.08.016_bib12","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.jtha.2023.04.022","article-title":"Maladaptive lymphangiogenesis is associated with synovial iron accumulation and delayed clearance in factor VIII-deficient mice after induced hemarthrosis","volume":"21","author":"Cooke","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.016_bib13","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.thromres.2015.07.019","article-title":"Evaluation of the toxicology and pharmacokinetics of recombinant factor VIII Fc fusion protein in animals","volume":"136","author":"Dumont","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.08.016_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/JBM.S103796","article-title":"Many factor VIII products available in the treatment of hemophilia A: an embarrassment of riches?","volume":"8","author":"Lieuw","year":"2017","journal-title":"J Blood Med"},{"key":"10.1016\/j.jtha.2025.08.016_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1538-7836.2004.00552.x","article-title":"Factors influencing therapeutic efficacy and the host immune response to helper-dependent adenoviral gene therapy in hemophilia A mice","volume":"2","author":"Brown","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.016_bib16","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/jth.14567","article-title":"Mechanisms of vascular permeability and remodeling associated with hemarthrosis in factor VIII-deficient mice","volume":"17","author":"Cooke","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.016_bib17","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1182\/blood-2011-08-367813","article-title":"Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs","volume":"119","author":"Dumont","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.08.016_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.biologicals.2015.05.012","article-title":"Manufacturing process used to produce long-acting recombinant factor VIII Fc fusion protein","volume":"43","author":"McCue","year":"2015","journal-title":"Biologicals"},{"key":"10.1016\/j.jtha.2025.08.016_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/jcp.18.4.465","article-title":"Partial thromboplastin time test with kaolin. Normal range and modifications for the diagnosis of hemophilia and Christmas disease","volume":"18","author":"Matchett","year":"1965","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jtha.2025.08.016_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102543","article-title":"Traumatic bleeding and mortality in mice are intensified by iron deficiency anemia and can be rescued with tranexamic acid","volume":"8","author":"Joseph","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.016_bib21","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1365-2516.2006.01348.x","article-title":"Histological changes in murine haemophilic synovitis: a quantitative grading system to assess blood-induced synovitis","volume":"12","author":"Valentino","year":"2006","journal-title":"Haemophilia"},{"issue":"Suppl 3","key":"10.1016\/j.jtha.2025.08.016_bib22","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.joca.2010.05.025","article-title":"The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse","volume":"18","author":"Glasson","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.jtha.2025.08.016_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/jcm13010225","article-title":"Blood-induced arthropathy: a major disabling complication of haemophilia","volume":"13","author":"Leuci","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtha.2025.08.016_bib24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/hae.14605","article-title":"Which part of the blood in the knee joint is responsible for its detrimental effects? (An experimental study on the knee joint in rabbits)","volume":"28","author":"Colak","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.08.016_bib25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1083\/jcb.22.2.351","article-title":"The uptake of iron in rabbit synovial tissue following intra-articular injection of iron dextran. A light and electron microscope study","volume":"22","author":"Ball","year":"1964","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jtha.2025.08.016_bib26","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/rheumatology\/keg220","article-title":"Haemoglobin-derived iron-dependent hydroxyl radical formation in blood-induced joint damage: an in vitro study","volume":"42","author":"Hooiveld","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jtha.2025.08.016_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cellimm.2015.12.008","article-title":"Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice","volume":"301","author":"Krishnamoorthy","year":"2016","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jtha.2025.08.016_bib28","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMra2312718","article-title":"Neonatal Fc receptor - biology and therapeutics","volume":"392","author":"Bussel","year":"2025","journal-title":"N Engl J Med"},{"issue":"Suppl 6","key":"10.1016\/j.jtha.2025.08.016_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia panelists and co-authors. WFH guidelines for the management of hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.08.016_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310824","article-title":"Proteoglycans in articular cartilage and their contribution to chondral injury and repair mechanisms","volume":"24","author":"Alcaide-Ruggiero","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2025.08.016_bib31","series-title":"Biochemistry, glycosaminoglycans. Treasure Island, FL","author":"Casale","year":"2023"},{"key":"10.1016\/j.jtha.2025.08.016_bib32","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.immunol.26.021607.090232","article-title":"Anti-inflammatory actions of intravenous immunoglobulin","volume":"26","author":"Nimmerjahn","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jtha.2025.08.016_bib33","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1002\/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6","article-title":"Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn","volume":"29","author":"Kim","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jtha.2025.08.016_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.20021829","article-title":"The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan","volume":"197","author":"Chaudhury","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtha.2025.08.016_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax9586","article-title":"Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex-mediated immune responses","volume":"5","author":"Blumberg","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.jtha.2025.08.016_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2567.1997.00326.x","article-title":"Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells","volume":"92","author":"Israel","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.jtha.2025.08.016_bib37","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.4049\/jimmunol.179.7.4580","article-title":"Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism","volume":"179","author":"Akilesh","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jtha.2025.08.016_bib38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41577-022-00821-1","article-title":"The therapeutic age of the neonatal Fc receptor","volume":"23","author":"Pyzik","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtha.2025.08.016_bib39","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200359","article-title":"FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex-driven autoimmunity","volume":"217","author":"Hubbard","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtha.2025.08.016_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0320322","article-title":"Synovial gene expression after hemarthrosis differs between FVIII-deficient mice treated with recombinant FVIII or FVIII-Fc fusion protein","volume":"20","author":"Chumappumkal Joseph","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2025.08.016_bib41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12288-015-0562-x","article-title":"Management of haemophilia in developing countries: challenges and options","volume":"32","author":"Ghosh","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.jtha.2025.08.016_bib42","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-2005-922219","article-title":"Hemophilia treatment in developing countries: products and protocols","volume":"31","author":"Srivastava","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.08.016_bib43","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12955-018-0908-9","article-title":"The impact of severe haemophilia and the presence of target joints on health-related quality-of-life","volume":"16","author":"O\u2019Hara","year":"2018","journal-title":"Health Qual Life Outcomes"},{"issue":"Suppl 4","key":"10.1016\/j.jtha.2025.08.016_bib44","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2516.2004.00976.x","article-title":"The target joint","volume":"10","author":"Mulder","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.08.016_bib45","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/jth.15268","article-title":"Systemic vascular basement membrane markers linked to synovial vascular remodeling are biomarkers of hemarthrosis in patients with hemophilia","volume":"19","author":"Gopal","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.016_bib46","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood.V126.23.3538.3538","article-title":"The propagation of hemophilic arthropathy - the role of abnormal angiogenesis and vascular remodeling in recurrent joint bleeding in adults with hemophilia","volume":"126","author":"Wesley","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.08.016_bib47","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1182\/bloodadvances.2023011366","article-title":"Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A","volume":"7","author":"Agosti","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.08.016_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2516.2010.02383.x","article-title":"Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels","volume":"17","author":"den Uijl","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.08.016_bib49","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa1803550","article-title":"Emicizumab prophylaxis in patients who have hemophilia A without inhibitors","volume":"379","author":"Mahlangu","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.08.016_bib50","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1016\/S2352-3026(23)00037-6","article-title":"Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A\/B): a multicentre, open-label, randomised, phase 3 trial","volume":"10","author":"Srivastava","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2025.08.016_bib51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/JBM.S490588","article-title":"Emerging therapies in hemophilia: improving equitable access to care","volume":"16","author":"Lewandowska","year":"2025","journal-title":"J Blood Med"},{"key":"10.1016\/j.jtha.2025.08.016_bib52","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1182\/bloodadvances.2023010511","article-title":"Hemophilia B and gene therapy: a new chapter with etranacogene dezaparvovec","volume":"8","author":"Anguela","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.08.016_bib53","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMoa2113708","article-title":"Valoctocogene roxaparvovec gene therapy for hemophilia A","volume":"386","author":"Ozelo","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.08.016_bib54","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s40259-023-00615-4","article-title":"Evaluating gene therapy as a potential paradigm shift in treating severe hemophilia","volume":"37","author":"Thornburg","year":"2023","journal-title":"BioDrugs"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625005422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625005422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:32:24Z","timestamp":1772890344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625005422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1538783625005422"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.08.016","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defective lymphangiogenesis and iron removal after hemarthrosis in factor VIII-deficient mice are rectified with therapeutic factor VIII administration\u2014implications for joint health","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}